According to the PitchBook Platform, 839 VC investors have backed at least one company in the global pharmaceutical & biotechnology industry over the past three years, during which nearly $16.9 billion has been invested over about 1,150 deals. After increasing each year between 2009 and 2013, deal count is on pace to take a dip in 2014; however, total capital invested in the pharma/biotech space so far this year ($6.8 billion) is already a seven-year high. Of all the investors, 190 manage between $100 million and $500 million of assets, while another 87 manage between $1 billion and $5 billion. 456 of the investors have been active in the industry within the past 12 months.
Click to explore the data on the PitchBook Platform